Th1/Th2 Cells in Patients with Multiple Myeloma
- 1 February 2004
- journal article
- review article
- Published by Taylor & Francis in Hematology
- Vol. 9 (1), 41-45
- https://doi.org/10.1080/10245330310001652437
Abstract
Multiple myeloma (MM) is a lymphoproliferative disorder that is characterized by a proliferation of clonal B cells in various stages of maturation that then infiltrate the bone marrow. MM has been reported to accompany various T cell abnormalities including quantitative and functional defects of CD4+ and CD8+ T cells. Recently, immunotherapy such as dendritic cell therapy, vaccination therapy, and anti-tumor antibody therapy, has been attempted in patients with MM. To develop more effective immunotherapy for patients with MM, further studies are required to identify the immunological abnormalities, especially in T cells, associated with MM. The T helper 1 (Th1) and T helper 2 (Th2) cells are characterized by distinct cytokine production patterns. The Th1 cells produce interferon γ and interleukin-2 (IL-2), and are involved in cell-mediated immunity. The Th2 cells produce IL-4 and promote humoral immunity by stimulating antibody production, particularly IgE responses. Furthermore, Th1 and Th2 cells have been found to cross-regulate each other's development. The Th1/Th2 combination has an important role in immune response to many disorders including infection, autoimmune diseases, and malignancies. In this review, we report a Th1/Th2 imbalance in cases of MM, and discuss the relationship between T cell abnormalities and the pathology of MM.Keywords
This publication has 37 references indexed in Scilit:
- Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cellsExperimental Hematology, 1999
- IL4 production and increased CD30 expression by a unique CD8+ T‐cell subset in B‐cell chronic lymphocytic leukaemiaBritish Journal of Haematology, 1999
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Serum thymidine kinase as a prognostic indicator for patients with multiple myeloma: results from the MRC (UK) V TrialBritish Journal of Haematology, 1993
- T Helper 1 (TH1) Functional Phenotype of Human Myelin Basic Protein-Specific T LymphocytesAutoimmunity, 1993
- Human TH1 and TH2 subsets: doubt no moreImmunology Today, 1991
- Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.JCI Insight, 1991
- Generation of T cell clones binding F(ab′)2 fragments of the idiotypic immunoglobulin in patients with monoclonal gammopathyCancer Immunology, Immunotherapy, 1991
- Comparative Analysis of Immunodeficiency in Patients with Monoclonal Gammopathy of Undetermined Significance and Patients with Untreated Multiple MyelomaScandinavian Journal of Immunology, 1989
- Abnormal monoclonal antibody‐defined helper/suppressor T‐cell subpopulations in multiple myeloma: relationship to treatment and clinical stageBritish Journal of Haematology, 1983